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ABSTRACT: Baggio-Yoshinari Syndrome (BYS) is an emergent 
Brazilian zoonosis that presents similarities with Lyme disease 
(LD), differing in some clinical and immunological aspects. 
Both diseases are caused by Borrelia Burgdorferi sensu lato, 
spirochetes transmitted to the vertebrate host by tick bites. In this 
study, an integrative review was aimed about the BYS, abranging 
large aspects like diseases history, clinical manifestations, immune 
events, diagnostic and treatment. A bibliographic survey was 
conducted in PubMed/MEDLINE, Scielo, Science Direct, Lilacs 
e Bireme databases, where 25 scientific articles were extracted 
for analysis, without temporal delimitation. It was evidenced the 
large geographical and biological diversity of Brazil contributed 
to the occurrence of changes in B. burgdorferi that results in 
SBY particularities. The bacterium, helped by proteins of the 
tick saliva can overcome immunological barriers to complete 
the infection. Initially, the diagnosis is based on the presence of 
oligoarthritis, and neurological, dermatological, cardiac or ocular 
symptoms may also be present, followed by the assessment of 
other clinical and laboratory criteria. The treatment consists in 
the use of doxycycline or amoxicillin associated with other drugs 
according to the clinical manifestations. The results suggest that 
SBY, despite the low number of studies about this pathology, is 
configured like an emerging disease that needs more attention 
from the scientific community to permit early disease diagnosis 
avoiding chronic events in the patients.
Keywords: Tick-Borne Diseases; Borrelia burgdorferi; 
Spirochaetales; Zoonoses; Ticks. 
RESUMO: A Síndrome de Baggio-Yoshinari (SBY) é uma 
zoonose emergente brasileira que apresenta semelhanças com 
a doença de Lyme (DL). Ambas são causadas pela espiroqueta 
Borrelia burgdorferi sensu lato, transmitida para hospedeiros 
vertebrados por meio de picadas de carrapato. Contudo, a SBY 
diverge da DL em alguns aspectos clínicos e imunológicos. No 
presente estudo, objetivou-se realizar uma revisão integrativa 
da literatura sobre a SBY, abordando aspectos amplos como 
história da doença, epidemiologia, manifestações clínicas, 
aspectos imunológicos, diagnóstico e tratamento. Foi realizado 
um levantamento bibliográfico nas bases de dados PubMed/
MEDLINE, SciELO, Science Direct, LILACS e Bireme, de 
onde foram extraídos 25 artigos científicos para análise, sem 
delimitação temporal. Evidenciou-se que a grande diversidade 
biológica e geográfica do país contribuiu para a ocorrência de 
modificações na B. burgdorferi que, possivelmente, resultaram 
nas particularidades da SBY. A bactéria, auxiliada por proteínas da 
saliva do carrapato, consegue transpor as barreiras imunológicas 
do hospedeiro para infectá-lo. Inicialmente, o diagnóstico baseia-
se na presença de oligoartrite, podendo também estar presentes 
sintomas neurológicos, dermatológicos, cardíacos ou oculares, 
seguindo-se com a avaliação de outros critérios clínicos e 
laboratoriais. O tratamento consiste na utilização de doxiciclina 
ou amoxicilina associada a outros fármacos de acordo com as 
manifestações clínicas. Nota-se que a SBY, apesar de pouco 
estudada, configura-se como uma doença emergente que necessita 
de maior atenção por parte dos setores de saúde pública e da 
comunidade científica para melhor caracterização do quadro 
clínico e, consequente realização de diagnóstico precoce, evitando 
acometimentos crônicos aos pacientes.
Descritores: Doenças transmitidas por carrapatos; Borrelia 
burgdorferi; Espiroqueta; Zoonoses; Carrapatos.
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INTRODUCTION
Baggio-Yoshinari Syndrome (BYS), also known as Brazilian Lyme-like disease, Lyme 
borreliosis or Brazilian borreliosis1,2, is an emerging 
Brazilian zoonosis with the first case report was dated in 
1992, in the city of São Paulo, Brazil3-5. It is similar to Lyme 
disease (LD), a typical disease in the northern hemisphere, 
presenting all the classic clinical manifestations of LD, but 
it differs in terms of the frequency of autoimmune episodes 
and events6-8.
Both are known to be caused by the spirochete 
Borrelia burgdorferi sensu lato, a bacteria classified as gram-
negative, but which does not produce lipopolysaccharide 
(LPS)1,9. However, it is speculated that BYS is caused 
by a genetically modified B. burgdorferi strain, with 
mutations in the flgE gene (responsible for the synthesis 
of flagellar structure) and the flaB gene (the main flagellin 
gene), which makes the spirochete assume an atypical 
morphology. From this perspective, it is assumed that 
the different geographical conditions of Brazil, combined 
with the great Brazilian biodiversity, mainly the existence 
of exotic species of ticks and other natural reservoirs, 
have contributed to the evolutionary adaptation of the 
pathogen in the country. Corroborating these investigations, 
it is described that the spirochetes found in the blood of 
patients with BYS are in their “L” form, characterized by 
the presence of a deficient cell wall, loss of flagella and 
with atypical morphology with a vegetative presentation, 
a characteristic probably resulting from changes due to 
unfavorable survival conditions3,6,9-15.
The bacteria has a zoonotic cycle in which ticks 
of the type Ixodes2 are usually included. But in Brazil, 
according to Gonçalves et al.2 and Mantovani et al.11 it 
was shown that these spirochetes are also present in ticks 
of the type Rhipicephalus, Amblyomma and Dermacentor 
(Figure 1), which transmit to dogs, horses, marsupials, 
rodents, opossums, cattle and humans1,16-19. B. burgdorferi 
infects ticks when they feed on the blood of infected 
hosts 1. However, despite the confirmation by serological 
techniques of the existence of this infection in humans and 
animals, the culture and isolation of B. burgdorferi has not 
yet been successfully performed in Brazil9,10.
Source: Own authorship, 2019.
Figure 1. Graphic representation of exemplos of ticks type Ixodes, Rhipicephalus, Amblyomma and Dermacentor
After being bitten by an infected tick, skin lesions 
may occur20,21. However, not all individuals become ill and 
the host may be presented as an asymptomatic carrier of 
the bacteria for years10,20. In the event of symptoms, the 
host may develop broad-spectrum clinical manifestations, 
such as neurological, joint, cardiac or ocular dermatological 
symptoms7,8,20. More recently, Costa and Yoshinari7 
describe that patients with BYS may also present clinical 
manifestations similar to autoimmune diseases, such as 
dry syndrome, inflammatory arthritis, idiopathic myositis, 
panniculitis, skin lesions compatible with scleroderma, 
vasculitis, antiphospholipid antibody syndrome and the 
occurrence of manifestations observed in systemic lupus 
erythematosus (SLE), such as Raynaud’s phenomenon, 
photosensitivity, butterfly wing injury and alopecia. Also, 
triggering or worsening of allergic processes to drugs or 
food may occur.
Concerning the laboratory alterations, the production 
of antibodies against autologous cellular components 
produced during the clinical evolution of the disease is 
noted, nevertheless, there are still few studies that address 
this theme1,3. The main changes reported by Costa and 
Yoshinari7 refer to the presence of ACF (anti-core factor), 
anti-Ro/La, anti-cardiolipin IgG/IgM, anti-neutrophil 
cytoplasm, neuronal and cutaneous anti-constituent 
antibodies, hypergammaglobulinemia and, in some cases, 
the elevation of IgE.
In view of the scarcity of studies, analyzes of aspects 
of BYS such as the history of the disease, epidemiology, 
clinical manifestations, immunological aspects, diagnosis, 
and treatment become relevant, as they broaden the 
discussion on the topic, in order to better understand this 
emerging disease in human beings. Therefore, the objective 
of the study was to conduct a literature review about aspects 
of the syndrome, with an emphasis on the clinical and 
immunological manifestations of BYS.
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METHODS
It is an integrative literature review, since it 
contributes to the process of systematization and analysis of 
results, allowing the understanding of a certain theme. After 
elaborating on the research question, a bibliographic survey 
was made in the databases PubMed/MEDLINE, SciELO, 
Science Direct, LILACS, BIREME, using the following 
descriptors: “Baggio-Yoshinari”, “Brazilian borreliosis”, 
“Brazilian Lyme-like”, without time delimitation, in 
English or Portuguese. The exclusion criteria were: theses, 
monographs, not available in their entirety, and research 
carried out with experimental models (rats and/or mice).
In the last step to analyze and compile the results, 
17 abstracts/articles were carefully read in order to 
organize and tabulate the data. Subsequently, due to the 
need for theoretical complementation of the specificities 
of the theme, the descriptor “Borrelia burgdorferi tick 
Brazil”, “Borrelia burgdorferi” was added to the PubMed/
MEDLINE and SciELO database, also without temporal 
delimitation. After applying the exclusion criteria, three 
original articles were identified in the respective databases. 
In addition to these, after a manual search, five articles 
were included in the final analysis, due to the thematic 
relevance about the object of study of this review. For the 
organization and tabulation of data, a complete reading of 
25 works was carried out, selected from a total of 1.307 
publications (Figure 2).
Source: Own authorship, 2020.
Figure 2. Flowchart for the selection of scientific articles on Baggio-Yoshinari Syndrome
RESULTS AND DISCUSSION
History of the disease and epidemiology
BYS was first described in Brazil in 1992, in the city 
of Itapevi, São Paulo. Two brothers were diagnosed after 
having a history of tick bite and subsequent development of 
fever, migratory erythema and arthritis4,5,10,19,20,22. However, 
there are case reports from 1988, in Rio de Janeiro, there 
was no description of clinical and laboratory symptoms. 
Subsequently, some cases were identified in humans and 
animals, by serological methods in Espírito Santo, Rio 
de Janeiro, São Paulo, Minas Gerais and Mato Grosso do 
Sul, Amazonas, Tocantins and Paraná, showing a large 
geographical distribution area for this infection3,16,23,24. 
According to Dall’Agnol et al.22, from 2009 to 2016, 4.078 
suspected cases of BYS were recorded in Brazil. A number 
of 679 of these cases had serological confirmation for the 
presence of B. burgdorferi. The number of identified cases 
reinforces the need to create surveillance strategies and 
actions. However, as reported by Gonçalves et al.2, BYS 
still has a poorly characterized epidemiology due to the 
lack of studies on this disease.
Studies such as those by Melo et al.16, by Montandon 
et al.17, and Nascimento et al.18, demonstrated that wild and 
domestic animals present serological evidence of infection 
by B. burgdorferi. Samples of dogs, horses, marsupials, 
rodents and opossums, analyzed in these studies, showed 
positive serology for antibodies anti-B. burgdorferi.
The majority of cases in human beings have 
been identified in inhabitants of rural areas, where the 
incidence of this zoonosis is high due to the proximity 
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to animals parasitized by ticks2. It is understood that the 
rural environment is the most favorable for the vector 
because of the generally inadequate sanitary conditions, 
climate and favorable environment. It is admitted that 
infections transmitted by tick bites are common in Brazil, 
due to their wide geographical distribution in the Brazilian 
territory¹². Furthermore, the study by Passos et al.20 revealed 
a positive association between the appearance of cutaneous 
manifestations related to infection in the summer and 
autumn seasons. This is probably due to the rainy season in 
Brazil that occurs in the months from October to March, in 
which the infectious forms of ticks are present in nature due 
to their evolutionary cycle, as they develop at temperatures 
below 28ºC/ 82,4o F.
Clinical manifestations 
B. burgdorferi found in Brazil presents differences 
that are considered responsible for the particularities in 
the clinical manifestation of BYS in relation to LD. Some 
authors suggest that the atypical cystic morphology of the 
bacteria, without periplasmic flagellum and with a decrease 
in the expression of external surface proteins (Osp), may 
justify the particularities of this strain, which may impact 
on the presentation of signs and symptoms by the host1,7,10,15.
In Brazil, BYS can have a long incubation period, 
ranging from months to years 25. A study by Gouveia 
et al.10, indicates variation from one day to six years 
between the tick bite and the appearance of the first clinical 
manifestations. Clinically, BYS can be divided into acute 
and/or recurrent latent stage (Figure 3). If the onset of signs 
and symptoms occurs within three months, it is defined as 
an acute stage of the disease10. At this stage, at the location 
of the bite in the vertebrate host, an initial lesion of the 
primary phase of the disease may appear, which is due 
to the inoculation of the infectious agent, constituting the 
chronic migratory erythema (CME). This is a characteristic 
clinical sign that presents itself as an exanthema associated 
with the increase in local temperature, progressing in a 
centrifugal way and evolving towards the formation of 
rings; however, variations can occur, such as triangular 
shapes or the appearance of erythematous plaques. CME 
can disappear without treatment and reappear in a localized 
or disseminated form about a month after the bite, a period 
that constitutes the secondary stage of the disease. This 
manifestation may be recurrent for years or may be absent 
in patients with BYS12,20,23. However, in some cases, it is 
observed that there is no manifestation of the acute stage. 
Given this fact, it is plausible to consider that individuals 
infected with B. burgdorferi can progress directly to the 
recurrent latent stage, which can last for years. In these 
cases, the host presents itself only as a carrier of the 
bacteria, so that, at a given point in life, the loss of immunity 
may result in a wide range of symptoms7,8. 
It is important that the diagnosis and treatment are 
established in the acute stage, avoiding irreversible sequelae 
and the evolution of chronic rheumatic, and neurological 
conditions10. In addition to cutaneous manifestations, this 
zoonosis includes osteoarticular, neurological, cardiac, 
psychiatric, ocular and immuno-allergic symptoms in its 
clinical spectrum7,8,12. The rheumatic condition of BYS 
usually affects large joints, such as the knee, with the 
occurrence of oligoarticular symptoms in approximately 
half of the patients at the beginning of the disease or during 
episodes of relapse. Studies indicate that the majority of 
patients with joint involvement also have some neurological 
impairment6,25.
Sourse: Own authorship, 2019.
Figure 3. Natural history of Baggio-Yoshinari syndrome
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Neurological alterations can be present in both the 
acute and latent stages of the disease and usually occur 
with the association of multiple symptoms. In the acute 
phase, the occurrence of meningism is evident, present 
in approximately half of the patients, associated, in most 
cases, with fever, nausea, vomiting and neck pain. Some 
patients have peripheral motor radiculitis, which triggers 
lesions mainly on the oculomotor, abducent and facial 
nerves; peripheral sensitive radiculitis; peripheral facial 
nerve palsy; and ocular symptoms, with retinal arteritis, 
optic neuritis and uveitis being the most common and 
serious complications; even though ocular disorders are not 
typical of BYS, they can affect up to 35% of patients6-8,12,20.
In addition to these changes, studies report the 
occurrence of psychiatric and psychosocial disorders 
in patients without a history of psychiatric illnesses. 
There are reports of cases in which the development of 
aggressive behavior and severe depression occurred, 
including suicidal ideation, lack of appetite and social 
withdrawal. Besides, some cases have been described in 
which patients had cognitive disorders that, despite not 
having specific symptoms, mainly include memory loss, 
language disorders and sleep disorders6. Therefore, the 
importance of psychological/psychiatric monitoring for 
patients diagnosed with BYS is emphasized, due to the 
possibility of these individuals to develop psychiatric 
manifestations of great repercussions.
According to the study by Kowacs et al.26, the 
occurrence of chronic headache occurs in association with 
the involvement of cranial nerves, eye diseases or temporal 
arteritis. However, the diagnosis of headache associated 
with BYS is difficult because of the appearance, generally, 
in the latent phase of the disease, in addition to being easily 
confused with primary headache chronicity or associated 
with the abuse of analgesics.
Immunological aspects
The tick comes into contact with B. burgdorferi 
when it feeds on an infected host. The bacteria migrate 
from the midgut to the salivary glands, mediated by Outer 
Surface Protein C (OspC), a protein expressed by this 
pathogen. Then, it is transported along with the spittle to 
the vertebrate host. It is recognized by several immune 
response mechanisms, such as the complement system 
(CS) and innate immunity cells. The recognition of B. 
burgdorferi by dendritic cells leads to the maturation of 
these cells and transcription of genes responsible for the 
expression of chemokines, apoptosis inhibitors, matrix 
metalloproteases and a wide spectrum of cytokines, 
including inflammatory mediators, neutrophil attractants 
and immunomodulatory cytokines. After the presentation 
of antigen by dendritic cells, the auxiliary CD4+ T cells 
Th1 and Th2 initiate the adaptive response, promoting the 
release of interferon-gamma (IFN-γ) and interleukin 4 
(IL-4), respectively, which are related to the acute phase 
manifestations. Subsequently, the cytokines released 
by CD4 + T lymphocytes induce the proliferation and 
differentiation of B lymphocytes and the production of 
antibodies1. 
The CS also participates in defenses against the 
bacteria and is activated by the classic route, the alternative 
route and the lectin route in the presence of B. burgdorferi 
infection. One of the CS’s mechanisms of action consists of 
the formation of pores in the spirochete envelope, through 
the action of the membrane attack complex (MAC), which 
through fragments C5b, C6, C7, and C8 and one or more 
molecules of C9, promote the formation of pores on the 
bacterial surface. The pores formed by MAC allow the 
influx of water and ions into the bacteria, which leads to 
their lysis by osmotic pressure. In addition, antibodies of 
the type IgG opsonize, that means, recover and promote 
their phagocytosis by binding the Fc receptors present in 
phagocytes27.
In spite of that, the pathogen uses mechanisms, 
during its transmission and dissemination, to evade and 
modulate the host’s innate and adaptive immune responses 
(Figure 4). It is known that there are salivary proteins of 
the tick that are able to help B. burgdorferi to circumvent 
the body’s defenses, with immunosuppressive, anti-
complement and anti-hemostatic activity. In this context, 
Salp15, a salivary protein induced by tick feeding, inhibits 
the activation and proliferation of CD4 T + lymphocytes 
specifically binding to the CD4 co-receptor of T cells. In 
addition, it interacts with the bacteria by binding to OspC, 
providing protection against antibodies and improving 
the survival of the pathogen after contact with the host. 
Furthermore, there are salivary proteins that inhibit B 
lymphocytes, dendritic cells, natural killer cells (NK), 
neutrophils and macrophages. Isac and Salp20 are two other 
proteins in tick spittle that inhibit the alternative pathway of 
CS activation. In addition, B. burgdorferi is able to suppress 
the activation of CS by the expression of complement 
regulatory proteins in its extracellular membrane, such 
as CRASPs (Complement Regulator Acquiring Surface 
Proteins)27 (Figure 5). In a study by Schuijt et al.27, in 
which the action of Salp15 for direct death protection by 
CS is described, it is reported that the inactivation of this 
defense mechanism is possibly crucial for the establishment 
of B. burgdorferi infection in the vertebrate host, as CS is 
constituted as an important strategy of the host’s immune 
system.
508
Silva VS, et al. Baggio-Yoshinari syndrome: a literature review
Source: Own authorship, 2019.
Figure 4. B. burgdorferi infection process and escape mechanisms from host response
Source: Own authorship, 2020.
Figure 5. Immune response to infection by B. burgdorferi
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Diagnosis
In Brazil, whenever the individual develops 
oligoarthritis of large joints a BYS research is accomplished, 
analyzing epidemiological and clinical antecedents. 
However, the BYS hypothesis should be considered not 
only in cases of oligoarthritis but in the occurrence of any 
of the systemic symptoms of zoonosis and/or in individuals 
who present epidemiology compatible with the tick bite or 
onset of symptoms after visiting the risky areas. 
The major parameters for diagnosis are: 1) 
positive epidemiology, 2) migratory erythema or systemic 
symptoms, such as ophthalmic, articular, neurological and 
cardiac manifestations, and 3) positive serology for B. 
burgdorferi. Serological confirmation is relevant, but due 
to the low specificity and sensitivity of serological tests in 
Brazil, the occurrence of false negatives and false positives 
are observed. As reported by Costa and Yoshinari7, the tests 
carried out at the Faculty of Medicine of the University of 
São Paulo present a frequency of positive results in 64.7% 
of patients with BYS and in 16% of those not infected; 
therefore, they conclude that this serology in the country 
is not useful as a screening procedure and care should be 
taken when using it as a diagnostic criterion. According to 
the authors above, in addition to Basile et al.1, the reason 
for the low specificity and sensitivity of the serological 
tests performed for the diagnosis of BYS is that, in these 
procedures, B. burgdorferi sensu stricto, B. garinii or B. 
afzelii antigens are used to evaluate immunoglobulins of 
B. burgdorferi senso lato found in Brazil.
 As a minor group of parameters is considered: 
1) history of systemic episodes compatible with BYS, 
2) symptoms of chronic fatigue syndrome (CFS), 3) 
autoimmunity disorders7,14,20,25. A positive BYS case is 
considered in the presence of three major parameters or 
two major and two minor. The disease is not a case of 
compulsory notification in Brazil, as it is not lethal in the 
acute phase. However, there are great financial costs to treat 
damage related to recurrent symptoms of the latent stage, 
caused, in most cases, by late diagnosis10.
The follow-up of several patients diagnosed with 
BYS allowed the characterization of two entities for the 
reaction manifestations: symptomatology compatible with 
CFS and another that concerns complications related to the 
malfunctioning of the immune system. During the evolution 
of BYS, patients may present symptoms compatible with 
autoimmune diseases. CFS, on the other hand, is an organic 
and acquired disease that manifests itself with neurological 
and immunological disorders, deficient energy production 
and inadequate cellular ion exchange, from the involvement 
of the spinal cord, and the central and peripheral nervous 
systems7. In view of this, it is possible to understand 
the difficulty in diagnosing patients with BYS, as this is 
configured as a complex disease in which the affected 
individual can develop several clinical and laboratory 
conditions as a way of progressing the disease.
Treatment
The treatment of BYS is not always satisfactory, 
especially if there is a delay in the clinical diagnosis. 
Antibiotic therapy is the same used in the treatment of 
classic DL, differing in terms of treatment time, which 
should be longer than three months when there is a delay 
in diagnosis1,6,7. The correct treatment is essential to avoid 
recurrence episodes since in Brazil patients who do not 
receive adequate treatment in the acute phase have a 
recurrence of symptoms in 75% of cases7,8,11. It is worth 
mentioning that the recurrence episodes are the most 
difficult to have therapeutic success, as there are cases of 
infectious recurrence and other patients who develop CFS 
symptoms and/or related to autoimmune diseases7,8,10. 
Thus, it is clear that, despite the efforts and achievements 
achieved, the treatment of BYS is not satisfactory in all 
cases, as BYS is not a single disease, but a constellation 
of complex infectious and reactive symptoms triggered by 
B. burgdorferi.
In the acute stage, doxycycline 100 mg is used twice 
daily for four weeks10,12,26 or amoxicillin 500 mg, four times 
a day, for four weeks10. For patients diagnosed in the latent 
stage, prolonged use of doxycycline 100 mg twice a day 
for three months is recommended12,26.
To treat neurological manifestations, ceftriaxone 
2 g/day/intravenous or penicillin 2.4 million units/day/
intravenous for 30 days is used, complemented by the use of 
oral antibiotics such as doxycycline (100 mg), administered 
twice a day for two to three months, which has the function 
of preventing future episodes of recurrence6,10,12,26. 
For cases of persistent joint pain even after 
treatment with the aforementioned options, there are reports 
of success when administering sulfasalazine 2 g/day or 
hydroxychloroquine 400 mg26. Antimalarial drugs have also 
been shown to be a useful drug as an immunomodulatory 
agent, helping to fight the inflammatory process, caused by 
inflammation and autoimmunity7,10,14. Unfortunately, there 
are no descriptions in the medical literature or references 
about the effective therapeutic approach to CFS, a relatively 
common complication in BYS.
CONCLUSION
Based on the information presented, it is noted that 
BYS is an emerging disease that deserves attention from 
the Public Health System and the scientific community. 
Despite the similarities with LD, which make the 
differentiation between the two zoonoses difficult, BYS 
has some particularities, such as progression to chronic 
events and the appearance of irreparable sequelae for the 
patient. We emphasize the need for further studies related 
to the implications of the Brazilian strain on clinical 
manifestations, and the development of more effective 
diagnostic methods and drugs in the treatment of BYS.
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